[1] Memorial Sloan Kettering Cancer Center,Myeloma Service, Department of Medicine
[2] Weill Cornell Medical College,Department of Medicine
[3] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Biostatistics
[4] New York,Division of Hematologic Malignancies II
[5] Center for Drug Evaluation and Research,Department of Medicine
[6] U.S. Food,Department of Medical Oncology
[7] and Drug Administration,Department of Hematology
[8] Massachusetts General Hospital,Division of Biometrics IX, Center for Drug Evaluation and Research
[9] Dana-Farber Cancer Institute,Department of Cancer Immunology, Institute for Cancer Research
[10] Erasmus University Medical Center,Department of Medicine
[11] U.S. Food and Drug Administration,Department of Medicine
[12] Oslo University Hospital Radiumhospitalet,Channing Division of Network Medicine, Department of Medicine
[13] Lovisenberg Diaconal Hospital,undefined
[14] Sylvester Comprehensive Cancer Center at the University of Miami,undefined
[15] Multiple Myeloma Research Foundation,undefined
[16] Brigham and Women’s Hospital and Harvard Medical School,undefined
[17] Harvard Medical School,undefined